The Signal Pathway for the Repressive Effect of Dipyridamole on Myofibroblast Transdifferentiation

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2018 Nov 20

PMID 30451359

Citations 3

Authors

Qiong Yan

Keisuke Ina

Seiichi Chiba

Huixing Wei

Shuji Tatsukawa

Yoshihisa Fujikura

Affiliations

Soon will be listed here.

Citing Articles

Effect of Beta-Blocker Consumption on the Severity and Extension of Perfusion Defects in Dipyridamole Myocardial Perfusion Single-Photon Emission Computed Tomography.

Shahlaee S, Falsoleiman H, Daloee M, Gholoobi A, Divband G, Raeisi N World J Nucl Med. 2024; 23(3):191-198.

PMID: 39170841 PMC: 11335382. DOI: 10.1055/s-0044-1787887.

Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula.

Chang T, Chen C, Hsieh H, Chen C, Hsu S, Cheng H Sci Rep. 2020; 10(1):12135.

PMID: 32699337 PMC: 7376157. DOI: 10.1038/s41598-020-69019-6.

The signal pathway for the repressive effect of dipyridamole on myofibroblast transdifferentiation.

Yan Q, Ina K, Chiba S, Wei H, Tatsukawa S, Fujikura Y J Cell Mol Med. 2018; 23(2):1608-1612.

PMID: 30451359 PMC: 6349209. DOI: 10.1111/jcmm.14006.

References

Hodgkins K, Schnaper H . Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol. 2011; 27(6):901-9. PMC: 3337413. DOI: 10.1007/s00467-011-1992-9. View

Meng X, Nikolic-Paterson D, Lan H . TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016; 12(6):325-38. DOI: 10.1038/nrneph.2016.48. View

Yan Q, Ina K, Chiba S, Wei H, Tatsukawa S, Fujikura Y . The signal pathway for the repressive effect of dipyridamole on myofibroblast transdifferentiation. J Cell Mol Med. 2018; 23(2):1608-1612. PMC: 6349209. DOI: 10.1111/jcmm.14006. View

Balakumar P, Varatharajan R, Nyo Y, Renushia R, Raaginey D, Oh A . Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats. Pharmacol Res. 2014; 90:36-47. DOI: 10.1016/j.phrs.2014.08.008. View

Hinz B . Myofibroblasts. Exp Eye Res. 2015; 142:56-70. DOI: 10.1016/j.exer.2015.07.009. View

Gillespie S, Tedesco L, Wang L, Bernstein A . The deubiquitylase USP10 regulates integrin β1 and β5 and fibrotic wound healing. J Cell Sci. 2017; 130(20):3481-3495. PMC: 5665446. DOI: 10.1242/jcs.204628. View

Wipff P, Rifkin D, Meister J, Hinz B . Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007; 179(6):1311-23. PMC: 2140013. DOI: 10.1083/jcb.200704042. View

Ayabe S, Kida T, Hori M, Ozaki H, Murata T . Prostaglandin D2 inhibits collagen secretion from lung fibroblasts by activating the DP receptor. J Pharmacol Sci. 2013; 121(4):312-7. DOI: 10.1254/jphs.12275fp. View

Singh L, Green K, Alexander M, Bassly S, Crook E . Hexosamines and TGF-beta1 use similar signaling pathways to mediate matrix protein synthesis in mesangial cells. Am J Physiol Renal Physiol. 2003; 286(2):F409-16. DOI: 10.1152/ajprenal.00007.2003. View

10.

Liu X, Geng Y, Xin S, Huang G, Tu X, Ding Z . Antithrombotic drug therapy for IgA nephropathy: a meta analysis of randomized controlled trials. Intern Med. 2011; 50(21):2503-10. DOI: 10.2169/internalmedicine.50.5971. View

11.

Insel P, Murray F, Yokoyama U, Romano S, Yun H, Brown L . cAMP and Epac in the regulation of tissue fibrosis. Br J Pharmacol. 2012; 166(2):447-56. PMC: 3417479. DOI: 10.1111/j.1476-5381.2012.01847.x. View

12.

Biel M, Michalakis S . Cyclic nucleotide-gated channels. Handb Exp Pharmacol. 2008; (191):111-36. DOI: 10.1007/978-3-540-68964-5_7. View

13.

de Rooij J, Zwartkruis F, Verheijen M, Cool R, Nijman S, Wittinghofer A . Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 1998; 396(6710):474-7. DOI: 10.1038/24884. View